Mpox No Longer A Global Health Emergency: WHO

In a significant update, the World Health Organization (WHO) announced on Thursday that Mpox no longer poses a global health emergency. This decision comes almost a year after the disease, formerly known as monkeypox, started spreading worldwide. WHO chief Tedros Adhanom Ghebreyesus cited declining case numbers worldwide as the primary reason for the change in classification. However, he emphasized that the disease remains a concern, particularly in certain regions of Africa where it has been prevalent for an extended period.

The WHO’s decision to remove Mpox from the list of global health emergencies follows closely on the heels of its declaration that Covid-19 no longer qualifies as a public health emergency of international concern (PHEIC). These developments reflect the evolving global health landscape and the progress made in combating both Mpox and the ongoing Covid-19 pandemic.

While the reclassification of Mpox signifies a positive trend, it is crucial to note that the disease still poses a threat, especially in African regions where it has persisted. The WHO urges continued vigilance and efforts to address Mpox effectively in these areas. Although Mpox may no longer carry the label of a global health emergency, it demands sustained attention to prevent its resurgence and mitigate its impact on affected communities.

The decision to remove Mpox from the global health emergency list underscores the effectiveness of ongoing prevention and control measures, as well as the collaborative efforts of healthcare organizations, governments, and communities worldwide. It serves as a testament to the progress made in managing Mpox and highlights the importance of sustained investment in public health infrastructure and disease surveillance.

The WHO’s decision provides an opportunity for countries and regions to shift their focus from emergency response to long-term strategies for Mpox prevention, detection, and treatment. It encourages healthcare systems to continue strengthening their capacity to respond to Mpox cases promptly and effectively.

As the global health community celebrates this milestone, it remains essential to stay vigilant and maintain robust surveillance systems to promptly identify and contain any potential outbreaks. The WHO will continue to monitor the situation closely, providing guidance and support to member countries as they navigate the evolving Mpox landscape.

Downward trend

Following the removal of Mpox from the global health emergency list, the World Health Organization (WHO) emphasized that the virus continues to impact communities globally, particularly in Africa where transmission patterns are not yet fully understood. While acknowledging the downward trend in Mpox cases worldwide, WHO chief Tedros Adhanom Ghebreyesus cautioned that the disease still presents significant public health challenges and requires a robust and sustainable response.

Travel-related cases remain a concern and contribute to the ongoing threat posed by Mpox. Tedros urged countries to maintain surveillance, access to tests, and availability of vaccines to effectively address the virus. Furthermore, he highlighted the importance of addressing stigma, which has hindered access to care for Mpox, particularly among the most affected communities. Tedros expressed gratitude that the feared backlash against these communities has largely not materialized.

The WHO chief also emphasized the heightened risk faced by individuals with untreated HIV, underscoring the need for comprehensive care and support for this vulnerable population. The monkeypox virus, responsible for causing Mpox disease, is primarily transmitted through close contact with infected humans or animals, as well as via contaminated materials such as sheets.

Originating in the Democratic Republic of Congo in 1970, Mpox had predominantly affected West and Central African nations until May of last year when it started to spread globally among diverse populations. While progress has been made, the WHO’s message underscores the ongoing need for a proactive response, including sustained surveillance, testing, vaccination, and addressing the challenges posed by stigma and discrimination.

As the global community continues to grapple with Mpox, concerted efforts and collaboration among nations, healthcare systems, and communities will be crucial in effectively managing the disease, protecting public health, and ensuring equitable access to care for all those affected. The WHO remains committed to supporting member countries in their efforts to address Mpox and mitigate its impact on communities worldwide.

Also Read: Google Makes Bard AI Available, But Privacy Concerns Remain